Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
CNP520 BACE Inhibitor Alzheimer's Disease (Phase 2/3) Amgen, Inc., Novartis Pharmaceuticals Corporation Amyloid-Related Small Molecule
JNJ-54861911 BACE inhibitor Alzheimer's Disease (Phase 2/3) Janssen, Shionogi Pharma Amyloid-Related Small Molecule
Thalidomide Thalomid® Alzheimer's Disease (Phase 2/3) Celgene Corporation Amyloid-Related, Inflammation Small Molecule